{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T17:48:33Z","timestamp":1789753713562,"version":"4.0.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T00:00:00Z","timestamp":1750377600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T00:00:00Z","timestamp":1750377600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Res"],"published-print":{"date-parts":[[2025,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>To clarify the clinical characteristics associated with coronary artery abnormality (CAA) in the acute phase of Kawasaki disease (KD) cases, we performed a cluster analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A retrospective cohort study of 103 KD cases that developed CAA (maximum Z-score for any coronary arteries &gt;2.5) within 30 days after disease onset was conducted among 726 consecutive KD cases. The hierarchical cluster analysis was performed based on 20 continuous variables before treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>101 out of 103 cases were clustered into 4 subgroups. Cluster 1 was a younger group characterized by leukocytosis and elevated serum triglyceride levels with frequent coronary artery dilation before treatment and good initial treatment responses. Cluster 2 was a younger group characterized by anemia and lower serum albumin and total cholesterol levels. Cluster 3 was an older group with frequent coronary artery dilation before treatment. Cluster 4 was an older group characterized by elevated serum aspartate aminotransferase, alanine aminotransferase, and total bilirubin levels, with poor treatment response and the lowest incidence of coronary artery dilatation before treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>We identified four subgroups with distinct features, suggesting different backgrounds for CAA development. Consideration of possible heterogeneity might be helpful for a better understanding of the pathophysiology and better treatment strategies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Impact<\/jats:title>\n                    <jats:p>\n                      <jats:list list-type=\"bullet\">\n                        <jats:list-item>\n                          <jats:p>To investigate possible heterogeneity in Kawasaki disease (KD) cases that developed coronary artery abnormality (CAA) in the acute phase and to evaluate associated clinical characteristics, we performed a cluster analysis in KD cases that developed CAA in the acute phase.<\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>Hierarchical cluster analysis in KD cases that developed CAA within 30 days after disease onset, based on clinical data before treatment, identified four subgroups with distinct features, suggesting different backgrounds for CAA development.<\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>Cluster analysis might be helpful for a better understanding of the pathophysiology and better treatment strategies in KD cases at high risk for developing CAAs.<\/jats:p>\n                        <\/jats:list-item>\n                      <\/jats:list>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1038\/s41390-025-04205-8","type":"journal-article","created":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T14:01:20Z","timestamp":1750428080000},"page":"1809-1816","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Heterogeneity in Kawasaki disease patients with coronary artery abnormalities investigated by data-driven cluster analysis"],"prefix":"10.1038","volume":"98","author":[{"given":"Yuto","family":"Sunaga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yohei","family":"Hasebe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natsumi","family":"Kikuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masashi","family":"Yoshizawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosuke","family":"Kono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuyuki","family":"Katsumata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Inukai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,20]]},"reference":[{"key":"4205_CR1","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1542\/peds.54.3.271","volume":"54","author":"T Kawasaki","year":"1974","unstructured":"Kawasaki, T., Kosaki, F., Okawa, S., Shigematsu, I. & Yanagawa, H. A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan. Pediatrics 54, 271\u2013276 (1974).","journal-title":"Pediatrics"},{"key":"4205_CR2","doi-asserted-by":"publisher","first-page":"e927","DOI":"10.1161\/CIR.0000000000000484","volume":"135","author":"BW McCrindle","year":"2017","unstructured":"McCrindle, B. W. et al. Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association. Circulation 135, e927\u2013e999 (2017).","journal-title":"Circulation"},{"key":"4205_CR3","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1016\/S0022-3476(75)80220-4","volume":"86","author":"H Kato","year":"1975","unstructured":"Kato, H., Koike, S., Yamamoto, M., Ito, Y. & Yano, E. Coronary aneurysms in infants and young children with acute febrile mucocutaneous lymph node syndrome. J. Pediatr. 86, 892\u2013898 (1975).","journal-title":"J. Pediatr."},{"key":"4205_CR4","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1056\/NEJM199106063242305","volume":"324","author":"JW Newburger","year":"1991","unstructured":"Newburger, J. W. et al. A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome. N. Engl. J. Med. 324, 1633\u20131639 (1991).","journal-title":"N. Engl. J. Med."},{"key":"4205_CR5","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1001\/jamapediatrics.2022.3756","volume":"176","author":"R Ae","year":"2022","unstructured":"Ae, R. et al. Incidence of Kawasaki disease before and after the COVID-19 pandemic in Japan: Results of the 26th Nationwide Survey, 2019 to 2020. JAMA Pediatr. 176, 1217\u20131224 (2022).","journal-title":"JAMA Pediatr."},{"key":"4205_CR6","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1038\/s41390-022-02194-6","volume":"93","author":"JJ Ashton","year":"2023","unstructured":"Ashton, J. J., Young, A., Johnson, M. J. & Beattie, R. M. Using machine learning to impact on long-term clinical care: principles, challenges, and practicalities. Pediatr. Res. 93, 324\u2013333 (2023).","journal-title":"Pediatr. Res."},{"key":"4205_CR7","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/S2352-4642(23)00166-9","volume":"7","author":"H Wang","year":"2023","unstructured":"Wang, H. et al. Subgroups of children with Kawasaki disease: a data-driven cluster analysis. Lancet Child Adolesc. Health 7, 697\u2013707 (2023).","journal-title":"Lancet Child Adolesc. Health"},{"key":"4205_CR8","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1111\/ped.14326","volume":"62","author":"T Kobayashi","year":"2020","unstructured":"Kobayashi, T. et al. Revision of diagnostic guidelines for Kawasaki disease (6th revised edition). Pediatr. Int. 62, 1135\u20131138 (2020).","journal-title":"Pediatr. Int."},{"key":"4205_CR9","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.jpeds.2006.03.050","volume":"149","author":"K Egami","year":"2006","unstructured":"Egami, K. et al. Prediction of resistance to intravenous immunoglobulin treatment in patients with Kawasaki disease. J. Pediatr. 149, 237\u2013240 (2006).","journal-title":"J. Pediatr."},{"key":"4205_CR10","first-page":"217","volume":"139","author":"AM Moran","year":"2000","unstructured":"Moran, A. M. et al. Abnormal myocardial mechanics in Kawasaki disease: rapid response to gamma-globulin. Am. Heart J. 139, 217\u2013223 (2000).","journal-title":"Am. Heart J."},{"key":"4205_CR11","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1111\/1744-9987.12754","volume":"23","author":"K Koizumi","year":"2019","unstructured":"Koizumi, K. et al. Plasma exchange downregulates activated monocytes and restores regulatory T cells in Kawasaki Disease. Ther. Apher. Dial. 23, 92\u201398 (2019).","journal-title":"Ther. Apher. Dial."},{"key":"4205_CR12","first-page":"401","volume":"5","author":"F Aldi","year":"2023","unstructured":"Aldi, F., Hadi, F., Rahmi, N. A. & Defit, S. Standardscaler\u2019s potential in enhancing breast cancer accuracy using machine learning. J. Appl. Eng. Technol. Sci. (JAETS 5, 401\u2013413 (2023).","journal-title":"J. Appl. Eng. Technol. Sci. (JAETS"},{"key":"4205_CR13","doi-asserted-by":"crossref","unstructured":"Thippa Reddy, G. et al. Antlion re-sampling based deep neural network model for classification of imbalanced multimodal stroke dataset. Multimedia Tools Appl. 81, 41429\u201341453 (2020).","DOI":"10.1007\/s11042-020-09988-y"},{"key":"4205_CR14","doi-asserted-by":"crossref","unstructured":"Dunteman, G. H. Principal components analysis. (Sage publication, California, 1989).","DOI":"10.4135\/9781412985475"},{"key":"4205_CR15","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1002\/wics.101","volume":"2","author":"H Abdi","year":"2010","unstructured":"Abdi, H. & Williams, L. J. Principal component analysis. WIREs Comp. Stat. 2, 433\u2013459 (2010).","journal-title":"WIREs Comp. Stat."},{"key":"4205_CR16","doi-asserted-by":"publisher","first-page":"2511","DOI":"10.1080\/00036846.2014.904491","volume":"46","author":"M Arg\u00fcelles","year":"2014","unstructured":"Arg\u00fcelles, M., Benavides, C. & Fern\u00e1ndez, I. A new approach to the identification of regional clusters: hierarchical clustering on principal components. Appl. Econ. 46, 2511\u20132519 (2014).","journal-title":"Appl. Econ."},{"key":"4205_CR17","volume":"7","author":"F Murtagh","year":"2017","unstructured":"Murtagh, F. & Contreras, P. Algorithms for hierarchical clustering: an overview, II. Wiley Interdiscip. Rev: Data Min. Knowl. Discov. 7, e1219 (2017).","journal-title":"Wiley Interdiscip. Rev: Data Min. Knowl. Discov."},{"key":"4205_CR18","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1093\/oxfordjournals.aob.a083391","volume":"18","author":"B Hopkins","year":"1954","unstructured":"Hopkins, B. & Skellam, J. G. A new method for determining the type of distribution of plant individuals. Ann. Bot. 18, 213\u2013227 (1954).","journal-title":"Ann. Bot."},{"key":"4205_CR19","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/bmt.2012.244","volume":"48","author":"Y Kanda","year":"2013","unstructured":"Kanda, Y. Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics. Bone Marrow Transplant. 48, 452\u2013458 (2013).","journal-title":"Bone Marrow Transplant."},{"key":"4205_CR20","doi-asserted-by":"publisher","first-page":"2606","DOI":"10.1161\/CIRCULATIONAHA.105.592865","volume":"113","author":"T Kobayashi","year":"2006","unstructured":"Kobayashi, T. et al. Prediction of intravenous immunoglobulin unresponsiveness in patients with Kawasaki disease. Circulation 113, 2606\u20132612 (2006).","journal-title":"Circulation"},{"key":"4205_CR21","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s00431-006-0223-z","volume":"166","author":"T Sano","year":"2007","unstructured":"Sano, T. et al. Prediction of non-responsiveness to standard high-dose gamma-globulin therapy in patients with acute Kawasaki disease before starting initial treatment. Eur. J. Pediatr. 166, 131\u2013137 (2007).","journal-title":"Eur. J. Pediatr."},{"key":"4205_CR22","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1007\/s10067-023-06502-1","volume":"42","author":"Y Sunaga","year":"2023","unstructured":"Sunaga, Y. et al. A simple scoring model based on machine learning predicts intravenous immunoglobulin resistance in Kawasaki disease. Clin. Rheumatol. 42, 1351\u20131361 (2023).","journal-title":"Clin. Rheumatol."},{"key":"4205_CR23","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/S0022-3476(05)82404-7","volume":"119","author":"E Salo","year":"1991","unstructured":"Salo, E., Pesonen, E. & Viikari, J. Serum cholesterol levels during and after Kawasaki disease. J. Pediatr. 119, 557\u2013561 (1991).","journal-title":"J. Pediatr."},{"key":"4205_CR24","first-page":"dgab230","volume":"10","author":"S Shao","year":"2021","unstructured":"Shao, S. et al. Predictive value of serum lipid for intravenous immunoglobulin resistance and coronary artery lesion in Kawasaki disease. J. Clin. Endocrinol. Metab. 10, dgab230 (2021).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4205_CR25","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1016\/S0140-6736(11)61930-2","volume":"379","author":"T Kobayashi","year":"2012","unstructured":"Kobayashi, T. et al. Efficacy of immunoglobulin plus prednisolone for prevention of coronary artery abnormalities in severe Kawasaki disease (RAISE study): a randomised, open-label, blinded-endpoints trial. Lancet 379, 1613\u20131620 (2012).","journal-title":"Lancet"},{"key":"4205_CR26","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1016\/S0140-6736(18)32003-8","volume":"393","author":"H Hamada","year":"2019","unstructured":"Hamada, H. et al. Efficacy of primary treatment with immunoglobulin plus ciclosporin for prevention of coronary artery abnormalities in patients with Kawasaki disease predicted to be at increased risk of non-response to intravenous immunoglobulin (KAICA): a randomised controlled, open-label, blinded-endpoints, phase 3 trial. Lancet 393, 1128\u20131137 (2019).","journal-title":"Lancet"},{"key":"4205_CR27","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s00431-008-0727-9","volume":"168","author":"K Okada","year":"2009","unstructured":"Okada, K. et al. Pulse methylprednisolone with gammaglobulin as an initial treatment for acute Kawasaki disease. Eur. J. Pediatr. 168, 181\u2013185 (2009).","journal-title":"Eur. J. Pediatr."},{"key":"4205_CR28","doi-asserted-by":"publisher","first-page":"e17","DOI":"10.1542\/peds.2011-0148","volume":"129","author":"S Ogata","year":"2012","unstructured":"Ogata, S. et al. Corticosteroid pulse combination therapy for refractory Kawasaki disease: a randomized trial. Pediatrics 129, e17\u2013e23 (2012).","journal-title":"Pediatrics"},{"key":"4205_CR29","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1016\/S0140-6736(13)62298-9","volume":"383","author":"AH Tremoulet","year":"2014","unstructured":"Tremoulet, A. H. et al. Infiximab for intensifcation of primary therapy for Kawasaki disease: a phase 3 randomised, double-blind, placebo-controlled trial. Lancet 383, 1731\u20131738 (2014).","journal-title":"Lancet"},{"key":"4205_CR30","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.118.011319","volume":"8","author":"MBF Son","year":"2019","unstructured":"Son, M. B. F. et al. Risk model development and validation for prediction of coronary artery aneurysms in Kawasaki Disease in a North American Population. J. Am. Heart Assoc. 8, e011319 (2019).","journal-title":"J. Am. Heart Assoc."},{"key":"4205_CR31","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCOUTCOMES.120.007191","volume":"14","author":"K Miyata","year":"2021","unstructured":"Miyata, K. et al. Risk factors of coronary artery abnormalities and resistance to intravenous immunoglobulin plus corticosteroid therapy in severe Kawasaki Disease: An Analysis of Post RAISE. Circ. Cardiovasc. Qual. Outcomes 14, e007191 (2021).","journal-title":"Circ. Cardiovasc. Qual. Outcomes"},{"key":"4205_CR32","doi-asserted-by":"publisher","first-page":"1321533","DOI":"10.3389\/fped.2023.1321533","volume":"11","author":"Y Murayama","year":"2023","unstructured":"Murayama, Y. et al. Risk factors for coronary artery abnormalities and resistance to immunoglobulin plus ciclosporin A therapy in severe Kawasaki disease: subanalysis of the KAICA trial, randomized trial for cicrosporin A as the first-line treatment. Front. Pediatr. 11, 1321533 (2023).","journal-title":"Front. Pediatr."},{"key":"4205_CR33","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1253\/circj.CJ-17-0046","volume":"82","author":"S Fuse","year":"2017","unstructured":"Fuse, S., Mori, T., Kuroiwa, Y. & Hirakawa, S. On what day of, illness does the dilatation of coronary arteries in patients with, Kawasaki disease begin?. Circ. J. 82, 247\u2013250 (2017).","journal-title":"Circ. J."},{"key":"4205_CR34","doi-asserted-by":"publisher","first-page":"2797","DOI":"10.1007\/s00431-021-04006-1","volume":"180","author":"T Suzuki","year":"2021","unstructured":"Suzuki, T. et al. Z score is a possible predictor of the risk of coronary artery lesion development in patients with Kawasaki disease in Japan. Eur. J. Pediatr. 180, 2797\u20132805 (2021).","journal-title":"Eur. J. Pediatr."},{"key":"4205_CR35","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.ijcard.2008.04.019","volume":"136","author":"MA Crystal","year":"2009","unstructured":"Crystal, M. A., Manlholt, C., Yeung, R. S. M., Smallhorn, J. F. & McCrindle, B. W. Coronary artery dilation after Kawasaki disease for children within the normal range. Int. J. Cardiol. 136, 27\u201331 (2009).","journal-title":"Int. J. Cardiol."},{"key":"4205_CR36","doi-asserted-by":"publisher","unstructured":"Jone, P. N. et al. Update on Diagnosis and Management of Kawasaki Disease: A Scientific Statement From the American Heart Association. Circulation 150. https:\/\/doi.org\/10.1161\/CIR.0000000000001295 (2024).","DOI":"10.1161\/CIR.0000000000001295"},{"key":"4205_CR37","doi-asserted-by":"publisher","first-page":"114069","DOI":"10.1016\/j.jpeds.2024.114069","volume":"271","author":"MP Anderson","year":"2024","unstructured":"Anderson, M. P. & Bard, D. A gentle introduction to latent class analysis for researchers in pediatrics. J. Pediatr. 271, 114069 (2024).","journal-title":"J. Pediatr."},{"key":"4205_CR38","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.jpeds.2020.09.043","volume":"229","author":"JC Burns","year":"2021","unstructured":"Burns, J. C. et al. Temporal clusters of Kawasaki disease cases share distinct phenotypes that suggest response to diverse triggers. J. Pediatr. 229, 48\u201353 (2021).","journal-title":"J. Pediatr."},{"key":"4205_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-01961-5","volume":"11","author":"JA Burney","year":"2021","unstructured":"Burney, J. A. et al. Temporal clustering of Kawasaki disease cases around the world. Sci. Rep. 11, 22584 (2021).","journal-title":"Sci. Rep."},{"key":"4205_CR40","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2021-051742","volume":"149","author":"SC Boos","year":"2022","unstructured":"Boos, S. C., Wang, M., Karst, W. A. & Hymel, K. P. Traumatic head injury and the diagnosis of abuse: a cluster analysis. Pediatrics 149, e2021051742 (2022).","journal-title":"Pediatrics"},{"key":"4205_CR41","doi-asserted-by":"publisher","first-page":"13948","DOI":"10.3390\/ijms241813948","volume":"24","author":"HC Kuo","year":"2023","unstructured":"Kuo, H. C. et al. Diagnosis, progress, and treatment update of Kawasaki disease. Int. J. Mol. Sci. 24, 13948 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"4205_CR42","doi-asserted-by":"publisher","first-page":"10093","DOI":"10.3390\/ijms231710093","volume":"23","author":"LS Chang","year":"2022","unstructured":"Chang, L. S. et al. Expression of Eosinophilic subtype markers in patients with Kawasaki disease. Int. J. Mol. Sci. 23, 10093 (2022).","journal-title":"Int. J. Mol. Sci."}],"container-title":["Pediatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41390-025-04205-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-025-04205-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-025-04205-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T17:04:28Z","timestamp":1762880668000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41390-025-04205-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,20]]},"references-count":42,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["4205"],"URL":"https:\/\/doi.org\/10.1038\/s41390-025-04205-8","relation":{},"ISSN":["0031-3998","1530-0447"],"issn-type":[{"value":"0031-3998","type":"print"},{"value":"1530-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,20]]},"assertion":[{"value":"2 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Research Ethics Committee of the University of Yamanashi Hospital (Approval Number 1698). Informed consent was obtained from the parents or guardians of the children who served as subjects of the investigation and, when appropriate, assent from the subjects themselves. Details that might disclose the identity of the subjects under study have been omitted.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from the individual patients or their parents.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}]}}